S-3 S-3 EX-FILING FEES 0001533998 DarioHealth Corp. 0001533998 2025-07-31 2025-07-31 0001533998 1 2025-07-31 2025-07-31 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

DarioHealth Corp.

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Equity Common Stock, $0.0001 par value per share 457(a) 8,772,489 $ 0.58 $ 5,088,043.62 0.0001531 $ 778.98
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 5,088,043.62

$ 778.98

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 778.98

Offering Note

1

(1) Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low prices for a share of the Registrant's Common Stock as reported on the Nasdaq Capital Market on July 29, 2025, which date is a date within five business days of the filing of this registration statement. (2) Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions. (3) Represents 8,772,489 shares of the registrant's Common Stock consisting of (i) 4,654,746 shares of the registrant's Common Stock issuable as dividends to the registrant's Series C Preferred Stock, Series C-1 Preferred Stock and Series C-2 Preferred Stock; (ii) 2,003,603 shares of the registrant's Common Stock issuable to certain holders of the registrant's Series B Preferred Stock and Series C Preferred Stock who entered into Amended and Restated Lock Up Agreements with the registrant; and (iii) 2,114,140 shares of the registrant's Common Stock issuable upon exercise of certain Common Stock purchase warrants by the registrant in connection with that certain credit agreement, dated as of April 30, 2025, by and between the registrant and the lender parties signatory thereto.